Literature DB >> 14999737

Solid-state characterization of mefenamic acid.

Ramesh Panchagnula1, Prakash Sundaramurthy, Omathanu Pillai, Shrutidevi Agrawal, Yasvanth Ashok Raj.   

Abstract

The purpose of this study was to characterize mefenamic acid (MA) from commercial samples and samples crystallized from different solvents. Various techniques used for characterization included microscopy (hot stage microscopy, scanning electron microscopy), intrinsic dissolution rate, differential scanning calorimetry (DSC), Fourier transform infrared (FTIR) spectroscopy and powder X-ray diffractometry (pXRD). The commercial samples varied in their crystal habit, thermal behavior, and intrinsic dissolution rate. It was found that the commercial samples were polymorphic Form I, which converted to Form II on heating in a DSC pan. Similarly, compression in an intrinsic dissolution rate (IDR) press resulted in the conversion of Form I to Form II. On the other hand, the samples recrystallized from different solvents under varying conditions yielded different crystal habits. Stirring and degree of supersaturation significantly influenced the crystal habit in all the solvents used in the study. Samples crystallized from ethanol and tetrahydrofuran yielded Form I, which behaved similarly to the commercial samples (M1 and M3). Recrystallization from ethyl acetate at a fast cooling rate yielded Form I, which on melting crystallized to Form II. The form I crystallized from ethyl acetate by fast cooling converted partially to form II on storing at ambient conditions. Forms I and II of MA were enantiotropically related. The results demonstrate the variable material characteristics of the commercial samples of MA and the influence of the crystallizing conditions on the formation of the polymorphs. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999737     DOI: 10.1002/jps.20008

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Concomitant polymorphism in confined environment.

Authors:  In Sung Lee; Alfred Y Lee; Allan S Myerson
Journal:  Pharm Res       Date:  2007-09-25       Impact factor: 4.200

2.  Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO.

Authors:  Taro Kojima; Kenjirou Higashi; Toyofumi Suzuki; Kazuo Tomono; Kunikazu Moribe; Keiji Yamamoto
Journal:  Pharm Res       Date:  2012-01-05       Impact factor: 4.200

3.  Additive-induced metastable single crystal of mefenamic acid.

Authors:  Eun Hee Lee; Stephen R Byrn; M Teresa Carvajal
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

4.  Quantum Chemical Study on Mefenamic Acid Polymorphic Forms.

Authors:  Svitlana V Shishkina; Yevhenii A Vaksler; Irina S Konovalova; Victoriya V Dyakonenko; Victoriya V Varchenko
Journal:  ACS Omega       Date:  2022-05-16

5.  Solid-state characterization of nevirapine.

Authors:  Mahua Sarkar; O P Perumal; R Panchagnula
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

6.  Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies.

Authors:  Dounia Sid; Milad Baitiche; Zineb Elbahri; Ferhat Djerboua; Mokhtar Boutahala; Zouhair Bouaziz; Marc Le Borgne
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.